Edgewise Therapeutics put volume heavy and directionally bearish
PremiumThe FlyEdgewise Therapeutics put volume heavy and directionally bearish
2M ago
Edgewise Therapeutics price target raised to $42 from $32 at RBC Capital
Premium
The Fly
Edgewise Therapeutics price target raised to $42 from $32 at RBC Capital
2M ago
Edgewise Therapeutics price target raised to $42 from $32 at Leerink
Premium
The Fly
Edgewise Therapeutics price target raised to $42 from $32 at Leerink
2M ago
Edgewise Therapeutics announces top-line data of EDG-7500
PremiumThe FlyEdgewise Therapeutics announces top-line data of EDG-7500
2M ago
RBC says Edgewise abstract leak ‘appears legitimate,’ supportive of ‘7500
Premium
The Fly
RBC says Edgewise abstract leak ‘appears legitimate,’ supportive of ‘7500
2M ago
Edgewise Therapeutics Unveils 2024 Equity Incentive Plan
Premium
Company Announcements
Edgewise Therapeutics Unveils 2024 Equity Incentive Plan
3M ago
‘Don’t Be Scared of Heights’: J.P. Morgan Suggests 2 Stocks to Buy
PremiumStock Analysis & Ideas‘Don’t Be Scared of Heights’: J.P. Morgan Suggests 2 Stocks to Buy
4M ago
Edgewise Therapeutics participates in a conference call with Piper Sandler
Premium
The Fly
Edgewise Therapeutics participates in a conference call with Piper Sandler
4M ago
Wedbush reveals three potential buyout targets for Biogen
Premium
The Fly
Wedbush reveals three potential buyout targets for Biogen
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100